<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-29T23:06:33Z</responseDate><request verb="GetRecord" identifier="oai:munzur-rdlopen.rawdatalibrary.net:munzur/2645" metadataPrefix="oai_dc">https://munzur-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:munzur-rdlopen.rawdatalibrary.net:munzur/2645</identifier><datestamp>2026-10-28T15:29:56Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_munzur_1</setSpec><setSpec>col_munzur_2</setSpec><setSpec>com_munzur_8</setSpec><setSpec>col_munzur_159</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>The role of A268V exon-7 polymorphism of PPARA in development of axial spondyloarthritis; [Aksiyal spondiloartrit gelişiminde PPARA'nın A268V ekson-7 polimorfizminin rolü]</dc:title><dc:creator>Akbulut, Ekrem</dc:creator><dc:creator>Yolbas, Servet</dc:creator><dc:creator>Ozgen, Metin</dc:creator><dc:subject>axial spondyloarthritis</dc:subject><dc:subject>disease risk</dc:subject><dc:subject>inflammation</dc:subject><dc:subject>peroxisome proliferator activated receptor alpha</dc:subject><dc:subject>polymorphism</dc:subject><dc:description>Objectives: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that mainly affects the axial skeleton. Peroxisome proliferator activated receptor alpha (PPARA) is an intracellular transcription factor, which play a role in inflammation and osteoblasting activity. This study is designed to investigate the relationship of NG_012204.2:p.Ala268Val polymorphism of PPARA with axSpA risk and its role in disease development. Methods: This study was conducted with 168 patients and 181 controls. Genotyping was done with MALDITOF. Gene expression level was analyzed by quantitative real time PCR (RT-qPCR). The protein homology models of PPARA were created with ProMod3. Ligand binding dynamics were tested using the AutoDock4 docking program. Statistical evaluations were made with SPSS (ver24) and GeneGlobe. Results: Our results showed that C&gt;T polymorphism causing NG_012204.2:p.Ala268Val change was associated with disease risk (p=0.024) and T allele increased disease risk 1.7 times (95% CI=1.070-2.594). PPARA expression decreased (p&lt;0.05) in individuals carrying the T allele. We determined that the ligand entry pocket was opened 1.1 Å in the polymorphic PPARA. Polymorphic change caused a decrease in the ligand binding affinity. Conclusions: Our results provide an important contribution to elucidating the development of axSpA and demonstrate the potential of PPARA as a marker for the diagnosis of axSpA.</dc:description><dc:publisher>De Gruyter Open Ltd</dc:publisher><dc:date>2022</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/munzur/2645</dc:identifier><dc:identifier>https://doi.org/10.1515/tjb-2021-0086</dc:identifier><dc:identifier>0250-4685</dc:identifier><dc:language>en</dc:language><dc:relation>Turkish Journal of Biochemistry</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://munzur-rdlopen.rawdatalibrary.net/tr/items/munzur/2645</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>